MariMed Appoints New CMO, Elects Directors
Ticker: MRMD · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1522767
| Field | Detail |
|---|---|
| Company | Marimed Inc. (MRMD) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $265,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: personnel-change, board-appointment, governance
Related Tickers: MRMD
TL;DR
MariMed beefs up medical team & board with new CMO and directors.
AI Summary
MariMed Inc. announced on August 9, 2024, the appointment of Dr. Michael K. Weitz as Chief Medical Officer and the election of two new directors, Dr. Michael K. Weitz and Ms. Jennifer L. Smith, to its Board of Directors. The company also disclosed compensatory arrangements for its officers.
Why It Matters
The appointment of a Chief Medical Officer and new board members suggests a strategic focus on medical aspects and governance, potentially impacting future product development and company direction.
Risk Assessment
Risk Level: low — This filing primarily concerns personnel changes and board appointments, which are routine corporate governance events.
Key Players & Entities
- MariMed Inc. (company) — Registrant
- Dr. Michael K. Weitz (person) — Appointed Chief Medical Officer and elected Director
- Ms. Jennifer L. Smith (person) — Elected Director
- August 9, 2024 (date) — Date of report and earliest event
FAQ
Who has been appointed as the new Chief Medical Officer for MariMed Inc.?
Dr. Michael K. Weitz has been appointed as the new Chief Medical Officer for MariMed Inc.
When was the earliest event reported in this Form 8-K?
The earliest event reported in this Form 8-K was on August 9, 2024.
Who were the individuals elected to MariMed Inc.'s Board of Directors?
Dr. Michael K. Weitz and Ms. Jennifer L. Smith were elected to MariMed Inc.'s Board of Directors.
What is the principal executive office address for MariMed Inc.?
The principal executive office address for MariMed Inc. is 10 Oceana Way, Norwood, MA 02062.
What other information is disclosed regarding officers in this filing?
The filing also discloses compensatory arrangements of certain officers.
Filing Stats: 729 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2024-08-09 17:04:17
Key Financial Figures
- $265,000 — ill receive annual base compensation of $265,000; will be eligible to receive an annual
Filing Documents
- mrmd-20240809.htm (8-K) — 28KB
- 0001522767-24-000069.txt ( ) — 142KB
- mrmd-20240809.xsd (EX-101.SCH) — 2KB
- mrmd-20240809_lab.xml (EX-101.LAB) — 20KB
- mrmd-20240809_pre.xml (EX-101.PRE) — 11KB
- mrmd-20240809_htm.xml (XML) — 2KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded with the Inline XBRL document). ********** SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MARIMED INC. Dated: August 9, 2024 By: /s/ Jon R. Levine Jon R. Levine President and Chief Executive Officer